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Abstract  
BACKGROUND: The increasing prevalence of allergic diseases and atopy is affected by sex, age 
and lifestyle factors. Obesity and excess weight are reported to be potential risk factors for atopy 
and specifically for asthma symptoms in children and adults.  
OBJECTIVE: To assess the relation between body mass index (BMI) and allergic diseases in 
patients of both genders, as well as association of BMI with atopy in healthy subjects.  
METHODS: BMI (kg/m
2
), skin-prick test and total serum immunoglobulin E levels were assessed in 
139 subjects: 109 were patients with allergic diseases (M to F ratio was 51:58) and 30 were healthy 
controls (M to F ratio was 6:24). 
RESULTS: The study population was grouped into asthma, asthmarhinitis, rhinitis, Urticaria 
oreczema and controls by BMI and sex. Females with the highest BMI were in asthma and 
urticaria/eczema group. Males with the highest BMI were in asthmarhinitis and urticariaeczema 
group. High BMI was associated with atopy in both genders of healthy controls. High levels of total 
IgE were in male allergic patients.  
CONCLUSION: High BMI was associated with asthma in females, urticaria/eczema in both genders 
and atopy in both genders of healthy controls. Higher levels of total IgE were concluded in male 
patients. 
 
 
 
 
 
Introduction 
 
The prevalence of allergic diseases in recent 
years is raising novel theories about causes and 
consequences. Genetic factors, hygiene hypothesis, 
interplay of environment factors along with obesity, 
are some of the most studied circumstances to be 
attributed to allergy. According to some studies, 
especially in last two decades, there is an increase in 
obesity among individuals; not only in industrialized 
countries but in developing ones too [1].
 
Also there is 
a link between obesity and allergy, based on other 
epidemiologic surveys, pointing out increased risk of 
asthmaand atopy among obese subjects [1, 2]. Even 
though there are still not fully explained mechanisms 
to be elucidated, some immune-modulator role of 
hormones and adipokines released from adipose 
tissue, have been described [2, 3]. It is well known 
that adipose tissue secretes many bioactive 
molecules (e.g. leptin and adiponectin)  involved in 
energy metabolism, but there are other functions 
performed by them, some resembling cytokines and 
others interleukins [e.g. tumor necrosis factor alpha 
(TNFα) and interleukin 6 (IL-6) [2, 4].  
Hence leptin, aside from being long term 
regulator of energy balance, is to be associated with 
inflammation regarding down regulation of regulatory 
T cells (Treg) and recruitment/activation of 
macrophages [4]. Serum levels of this hormone are 
proportionally correlated to adipose mass and 
furthermore increased leptin levels are reported 
among obese subjects with asthma compared to 
healthy controls, suggesting its inflammatory 
characteristics [5]. Similarly, adiponectin role in 
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energy metabolism is well established, serum levels 
are inversely correlated with body fat percentage in 
adults and it has anti-inflammatory effect [6]. Down 
regulation of IL10 secretion from macrophages and 
adipocytes, has been proved in many animal studies 
and its anti-inflammatory effect is supported by lower 
levels in obese compared to non-obese children with 
asthma [3, 6]. Taken together these two adipokines 
are to change immunological mechanisms, resulting in 
hyper-reactive immune system, decreased 
immunological tolerance and shift to TH2 cytokine 
profile, which increases risk of obesity-associated 
autoimmune diseases and allergy [1, 6].   
Several studies have emphasized negative 
relation between high body mass index (BMI) and 
bronchial reversibility in children with allergic rhinitis 
and asthma, positive association with prevalence of 
wheezing and eczema but no significant effect 
modification by either age or gender [7, 8]. However, 
some other studies reported no association between 
high BMI and doctor diagnosed or self reported 
asthma or allergy in young adults (age 26-29 year) [9, 
10]. Yet, another survey demonstrated association 
between obesity and asthma (with or without allergic 
rhinitis) but not between obesity and allergic rhinitis 
only and pointed out that “The increased risk of 
asthma in young Swedish men with obesity has 
remained unchanged over a period of three decades" 
[1].  Another conflicting matter is association of IgE 
and BMI in allergic patients. Considering that high 
total IgE levels correlate with allergic diseases and 
prevalence of  later ones correlate with high BMI, 
there is to be hypothesized an association between 
high total IgE levels and overweight or obesity in 
allergic patients as well as in atopic healthy controls 
with high BMI [12].  Nevertheless, several studies 
revealed the link between obesity and increased 
levels of total serum IgE in female patients with non-
atopic respiratory allergies but no significant 
difference in serum total IgE levels according to BMI 
in male patients [13].  
Eventually discrepancies exist among 
researchers about relation between total IgE, as 
marker of atopy, high BMI and allergic diseases, 
probably due to different ages of study population and 
specific outcomes to be expected; hence we decided 
to analyze these variables among our allergic patients 
and healthy controls with or without atopy.   
 
 
Material and Methods 
 
Subjects 
This study included 139 subjects: 109 were 
randomly selected untreated outpatients who 
experienced allergy symptoms of asthma, rhinitis and 
skin allergies as acute urticariaoreczema (M to F ratio 
was 51:59) and were referred to the Allergy & Clinical 
Immunology outpatient service at the UCC Prishtina. 
We excluded patients with dermatographysm, and 
pregnant women. Thirty healthy volunteers, as control 
group, were medical staff (M to F ratio was 6:24) 
selected according to answers about not having, nor 
ever had, symptoms of respiratory allergies (coughing, 
sneezing, itching and nose discharge).  
The patients were grouped according to their 
doctor diagnosed allergic disease; healthy volunteers 
according to their positive or negative reaction to skin 
prick test; all participants were grouped in obese and 
non-obese according to their body mass index (BMI), 
where BMI was classified as low (BMI, < 18.5 kg/m
2
), 
normal (18.5-24.9 kg/m
2
), overweight (25-29.9 kg/m
2
) 
and obesity (BMI, > or = 30 kg/m
2
), according to the 
World Health Organization (WHO), the US Preventive 
Services Task Force and the International Obesity 
Task Force. 
 
Study design 
Informed written consent was obtained from 
all participants who were than included in the 
research. To each subject was handed over a study 
questionnaire requesting socio-demographic 
characteristics, including age and gender; height and 
weight were measured using a stadiometer and an 
electronic scale, respectively, under the supervision of 
the researchers; the BMI was calculated according to 
the body weight divided by the square of height 
(kg/m
2
); family history of atopy, respiratory symptoms 
and skin rashes/hives were recorded.  
Protocol for the research project was 
approved by the Medical Faculty ethics committee. 
 
Blood sampling 
For the measurement of total IgE, venous 
blood (2 mL) was obtained at 9:00 a.m. Blood 
samples were allowed to clot at room temperature and 
the serum was separated by centrifugation at 1,200×g 
for 10 minutes and stored at -80℃. Sera were thawed 
at room temperature before measurements. Total IgE 
levels were measured by RIA, using Immunotech 
Beckman Coulter company products (France) at the 
laboratory of Endocrinology, Institute of Physiology, 
UCC Prishtina. Bound radioactivity was calculated 
with Gamma counter and values more than 183 IU/ml 
were considered raised. 
 
Skin prick test  
All participants were subjected to SPT with 
test kit G aeroallergens, Allergopharma product 
(Reinbeck Germany), along with positive control – 
histamine (1mg/ml) and negative – saline. Allergenic 
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extracts included 4 groups of aeroallergens: pollens, 
house dust mites, animal dander and moulds. The 
allergenic extract was placed on to the volar surface 
of forearm and introduced into the epidermis with 
sterile lancet (1 mm depth), new for each allergen. For 
each subject, 15 minutes later, both diameters of skin 
reaction were recorded and SPT was considered 
positive if diameter >3 mm. 
 
Statistical analyses     
Data are presented as the median and range. 
Kruskal−Wallis variance analysis was used for 
screening differences among the five groups. Fisher 
exact test was used to compare differences between 
two groups among healthy controls (with and without 
positive skin prick test). P−values less than 0.05 were 
considered significant. 
 
 
Results  
 
The overall male to female ratio of one 
hundred thirty nine participants was 57:82. One 
hundred and nine subjects were patients with doctor 
diagnosed allergic diseases, as allergic rhinitis 60.5% 
(Rh), allergic asthma with rhinitis 18.35% (A/Rh), 
allergic asthma without rhinitis 7.3% (A) and 
urticariaoreczema 13.7% (U/Ecz).  Among 30 healthy 
controls 37% reacted positive to at least one allergen 
on skin prick test.  
The overall median age was 30.6 years 
(range 11-59, SD 11.9) with male (M) to female (F) 
ratio 26.9:33.1 years respectively, and according to 
diseases and age groups the median age in A group 
was 29.4 years (range 12-55), 29.1 years in A/Rh 
group (range 11-54), 28.5 years in Rh (range 11-59), 
38.8 years in U/Ecz group (range 21-53) and 32.4 
years in healthy volunteers (range 14-57) (As shown 
in Table 1).  
 
Table 1: General characteristics of participants in relation to 
BMI and diseases. 
  
A 
n=8 
A/Rh 
n=20 
Rh 
n=66 
U/Ecz 
n=15 
Control 
n=30 
P-value 
Gender N(%)   
F 4 (50.0) 10 (50.0) 32 (48.5) 12 (80.0) 24 (80.0) 
P>0.05 
M 4 (50.0) 10 (50.0) 34 (51.5) 3 (20.0) 6 (20.0) 
Age yr. 
(Mean ± SD) 
29.4 ± 18.0 29.1 ± 13.9 28.5 ± 10.7 38.8 ± 9.5 32.4 ± 11.1  P= 0.017 
BMI N (%)   
Normal 5 (62.5) 12 (60.0) 41 (62.1) 7 (46.7) 17 (56.7)   
Overweight  2 (25.0) 8 (40.0) 22 (33.3) 4 (26.7) 12 (40.0) 
 
Obese 1 (12.5) - 3 (4.6) 4 (26.7) 1 (3.3)   
A- asthma without rhinitis; A/Rh – asthma with rhinitis; Rh – rhinitis only; U/Ecz – 
urticaria/eczema; F- Female; M- Male; BMI- body mass index (normal= 18.5-24.9 kg/m
2
, 
overweight = 25-29.9 kg/m
2
, obese >30 kg/m
2
). 
 
When calculating BMI, we found out that 44% 
of all cases were overweight and obese, especially 
urticaria/eczema group with 55.3%. Nevertheless we 
found the same percentage among healthy controls 
with positive skin prick test results (As shown in Table 
2). After evaluating gender differences, we noticed 
that females with asthma and urticaria oreczema were 
50% overweight and/or obese (BMI median 25.6 
kg/m
2
 range 24.6-26.4 and 27.7 kg/m
2 
respectively) 
compared to other groups as well as controls.  
 
Table 2: General characteristics of healthy controls in relation 
to skin prick test results, BMI, age and gender. 
  
Skin prick test 
Control 
n=30 
Positive 
n=11 
Negative 
n=19 
Gender N(%)   
F 9 (81.8) 15 (78.9) 24 (80.0) 
M 2 (18.2) 4 (21.1) 6 (20.0) 
Age yr.  
(Mean ± SD) 31.8 ± 13.3 32.7 ± 10.0 32.4 ± 11.1 
BMI N(%) 
 Normal 5 (45.5) 12 (63.2) 17 (56.7) 
Overweight  5 (45.5) 7 (36.8) 12 (40.0) 
Obese 1 (9.0) - 1 (3.3) 
 
F- Female; M- Male; BMI- body mass index (normal= 18.5-24.9 kg/m2, overweight = 25-29.9 kg/m2, 
obese >30 kg/m2). 
 
Nevertheless, males in A/Rh group were 50% 
overweight, 66.6% in urticariaor eczema group and 
66.7% in healthy controls (As shown in Table 3).  So 
after analyzing skin prick test positive and negative 
subjects among healthy controls, with a purpose to 
find any connection between atopy, gender and BMI, 
we found out that 55.6 % of skin prick test positive 
females and 50% of males were overweight compared 
to non atopic ones. Hence males were much more 
overweight compared to females among almost all 
disease groups, except for asthma group, and among 
healthy controls too.  
 
Table 3: Average of BMI in patients, according to gender and 
diseases, and compared to controls. 
  BMI 
A         
(n=8) 
A/Rh 
(n=20) 
Rh    
(n=66) 
Urticaria 
(n=15)  
Controls 
 (n=30)   
  N 4 10 32 12 24 
F 
Median 
(range) 
25.6 21.8 23.0 27.4 24.0 
(24.6-26.4) (18-28) (15.8-32.8) (20-42) (16.7-36.2) 
          
Normal 2 (50.0) 7 (70.0) 21 (65.6) 6 (50.0) 15 (62.5) 
Overweight 2 (50.0) 3 (30.0) 9 (28.1) 3 (25.0) 8 (33.3) 
Obese - - 2 (6.3) 3 (25.0) 1 (4.2) 
M 
N 4 10 34 3 6 
Median 
(range) 
22.4 25 23.4 28.4 25 
(16.9-46.0) (15.3-29.4) (10.0-31.5) (24.3-31.9) (23.4-29.4) 
          
Normal 3 (75.0) 5 (50.0) 20 (58.8) 1 (33.3) 2 (33.3) 
Overweight - 5 (50.0) 13 (38.2) 1 (33.3) 4 (66.7) 
Obese 1 (25.0) - 1 (2.9) 1 (33.3) - 
 
A- asthma without rhinitis; A/Rh – asthma with rhinitis; Rh – rhinitis only; U/Ecz – urticaria/eczema;  
BMI- body mass index (normal= 18.5-24.9 kg/m2, overweight = 25-29.9 kg/m2, obese >30 kg/m2). 
 
In respect to total IgE levels we found 
significant differences between subjects with allergies 
and healthy controls in both genders (As shown in 
Table 4); however in females the highest median 
value was among Rhinitis group and the lowest in 
urticaria oreczema group (Median 68.6 IU/ml range 
4.9-354 and 14.3 IU/ml range 0.44-120.4 respectively) 
and also we found interesting results of total IgE 
levels among healthy female controls because those 
who were positive to skin prick test resulted with 
higher median value compared to non-atopic (Median 
Clinical Science 
_______________________________________________________________________________________________________________________________ 
_______________________________________________________________________________________________________________________________ 
  72                                                                                                                                                                                                                       http://www.mjms.mk/ 
http://www.id-press.eu/mjms/ 
 
89.9 IU/ml range 11.1-174.5 and 15.4 IU/ml range 2.3-
168.6 respectively).   
Whereas males, being much more overweight 
than females, resulted with higher median level of 
total IgE in all disease groups, compared to controls 
and compared to female patients, particularly in 
urticaria/eczema male patients we found the highest 
median level of total IgE (350 IU/ml range 161-350) 
but not in rhinitis group were it was the lowest one 
(83.9 IU/ml range 4.39-350) (Table 4). 
 
Table 4:  Association between diseases, BMI and serum total IgE levels in patients and healthy controls. 
    A=8    A/Rh=20 Rh=66 Urt/ecz=15 Controls=30 
 
Females 
 
n=4 
 
n=10 
 
n=32 
 
n=12 
 
n=24 
P-value 
Age yr.  
(Mean ± SD) 
44.0 ± 13.2 30.0 ± 13.4 30.9 ± 10.4 40.0 ± 9.1 32.1 ± 10.8 P= .03 
Normal 2 (50.0) 7 (70.0) 21 (65.6) 6 (50.0) 15 (62.5) 
 
Overweight 2 (50.0) 3 (30.0) 9 (28.1) 3 (25.0) 8 (33.3) 
Obese - - 2 (6.3) 3 (25.0) 1 (4.2) 
Ig
E
 I
U
/m
l 
M
e
d
ia
n
 (
R
a
n
g
e
) Normal 
24.7 
(7.2 - 263.7) 
49.5 
(4.9 - 211.0) 
68.6 
(17.7 - 354.0) 
25.3 
(0.4 - 61.8) 
25.8 
(2.3 - 174) 
P= .012 
Overweight 
21.4 
(18.7 - 24.5) 
55.2  
(39.3 - 300) 
63.5 
(4.9 - 182.3) 
39.2 
(6.8 - 71.6) 
11.1 
(3.1 - 94.0) 
Obese - - 
58.5  
(44 - 73) 
9.1 
(5.7-120.4) 
174.5 
(174.5 - 174.5) 
Total 
21.4 
(7.16 - 263.7) 
49.6 
(4.85 - 211) 
68.6 
(4.9 - 354) 
14.3 
(0.44 - 120.4) 
22.15 
(2.3 - 174.5) 
P-value P>0.05 P>0.05 P>0.05 P>0.05 P>0.05 
 
Males 
 
n=4 
 
n=10 
n=34 
 
n=3 
n=6 
 
Age yr.  
(Mean ± SD) 
14.8 ± 2.8 28.2 ± 15.1 26.1 ± 10.6 34.0 ± 11.8 33.5 ± 13.2 P= .047 
Normal 3 (75.0) 5 (50.0) 20 (58.8) 1 (33.3) 2 (33.3) 
 
Overweight - 5 (50.0) 13 (38.2) 1 (33.3) 4 (66.7) 
Obese 1 (25.0) - 1 (2.9) 1 (33.3) - 
Ig
E
 I
U
/m
l 
M
e
d
ia
n
 (
R
a
n
g
e
) Normal 
68.9 
(68.9-68.9) 
239.4 
(18-250.7) 
67.3 
(4.4-134.7) 
161  
(161-161) 
20.2 
(17.7-22.7) 
P= .029 
Overweight - 
58.4 
(14.8-227.3) 
94.2 
(18.7-257.7) 
350 
(350-350) 
11.7 
(1.5-93.2) 
Obese 
75  
(75-75) 
- 
309 
(309-309) 
205 
(205-205) 
- 
Total 
300 
(68.9 - 350) 
228 
(14.8 - 350) 
83.9 
(4.39 - 350) 
350 
(161 - 350) 
16.9 
(1.5 - 93.2) 
P-value P>0.05 P>0.05 P>0.05 P>0.05 P>0.05 
 
 
A- asthma without rhinitis; A/Rh – asthma with rhinitis; Rh – rhinitis only; U/Ecz – urticaria/eczema;  
BMI- body mass index (normal= 18.5-24.9 kg/m2, overweight = 25-29.9 kg/m2, obese >30 kg/m2). 
 
 
 
 
 
Discussion   
 
Currently there is a debate about association 
between overweight and allergic diseases, as well as 
overweight and atopy, because some studies support 
this association and others don’t [1, 2, 7, 9, 11]. This 
is probably due to different study designs, different 
ages of study population and sometimes very small 
sample size for assessing inquired association and 
providing conclusive results, as is the case with our 
study. The fact that we found association between 
overweight and asthma in females, but not in males 
could be because the gender is an important modifier 
of BMI-related asthma risk in adolescents as well as in 
adults, according to some studies performed in larger 
size samples [16-18]. This point out some 
documented influence of sex hormones that might 
affect asthma mechanisms, especially when it comes 
to estrogen and progesterone imbalance in females. 
Considering that progesterone up- regulate beta2 
receptors, there have been hypothesis that obesity 
may reduce progesterone levels and hence reduces 
beta2adrenoreceptor function, which in turn will reduce 
bronchial smooth muscle relaxation. However we 
found no low levels of progesterone in asthma female 
subjects (data not published yet). On the other hand, 
estrogen may have dual effect on asthma and BMI 
was positively associated with plasma estrogen  in 
postmenopausal women in some studies reveling 
immune-modulating effect of estrogen in dose 
dependent manner, matter that we should further 
evaluate  [19]. The lack of association between BMI 
and asthma in males are similar to findings of Leenen 
et al. who reported that sex hormone alterations were 
associated with visceral fat accumulation in women 
but not in men [20].  However the men age of 14.8 
years in our asthma males could also be the reason 
for the discrepancy between asthma groups, because 
Joseph et al. reported associations of BMI, 
hospitalization and missed school days for asthma in 
male adolescents only [21]. Eventually these facts 
once again confirm that asthma dominates in males in 
adolescence but reverses in adulthood being most 
abundant in females.                                 
Although we found the strongest association 
between BMI and urticaria/eczema in both genders, 
similar to some studies conducted by Silverberg et al. 
in American adults and Lee et al. in Chinese adults, 
several other studies failed to support association 
between obesity and atopy in adults, such are those 
conducted by Flaxeder et al. and Jarvis et al. [11, 22-
24]. Taken all together our data supports the link 
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between overweight and eczema/urticaria, probably 
due to proinflamatory cytokines secreted in adipose 
tissue, or restricted physical activity, sedentary life 
and high energy intake in adults, including the idea of 
some other specific relationship between obesity and 
eczema/urticaria, but don’t establish the cause-effect 
relationship.  
It is noteworthy that significant experimental 
evidence suggests causal relation between atopy and 
obesity in healthy women reporting high levels of 17ß-
estradiol in obese compared to non-obese healthy 
women [25]. Our results also support these findings, 
because among healthy controls skin prick positive 
women were 55.6 % overweight/obese, compared to 
skin prick test negative ones, suggesting that the 
predisposition toward a humoral-mediated immune 
response could be linked to steroidogenic enzyme 
content of adipose tissue for estrogen synthesis  [27].                          
Also, the fact that several studies have found 
association between allergic diseases and overweight 
females only is not supported in this study because 
our results reveal association of high BMI with A/Rh 
and ezema/urticaria in male subjects too [19, 20, 26].
 
Furthermore, when differentiating between skin prick 
test positive and negative healthy controls, we found 
higher BMI among atopic ones. This could be, 
partially, because of the higher BMI in almost all male 
subjects in this study compared to females, and could 
be supported by the fact that men have a lesser 
percentage of body fat than women for a given BMI so 
higher BMI within the same overweight /obese group 
could be the risk factor for allergic diseases and atopy 
in males [28]. 
Nevertheless, we found higher total IgE levels 
among male patients, within all disease groups, 
compared to female patients and especially healthy 
controls. These results are similar to some studies 
and in contrast to others [13, 14]. In a large cohort 
study in asthma patients, conducted by Borish et al., it 
was reported that mean total IgE levels were higher 
among children and adolescents compared to adults, 
and males have  higher IgE levels than females  [14]. 
This is also supported by our study within all disease 
groups, because mean total IgE level was very high in 
asthma male subjects being adolescents (mean age 
14.8 years) compared to female adults (mean age 44 
years), and also very high IgE levels were related to 
gender but not to age in other disease groups. The 
higher levels of total IgE in males were largely related 
to cigarette smoking in some studies but not in others 
so when adjusted for smoking status we found out 
that 25%-50% of females in the study and the control 
group reported smoking habits, compared to males 
who reported smoking habits only in A/Rh and Rh 
group and with lower percentage than females with 
the same disease [29, 30]. So High IgE levels are not 
related to cigarette smoking in our male subjects. The 
strongest association of total IgE, BMI and disease 
was determined for eczema/urticaria in males, 
probably due to higher overall levels of IgE in males 
[11, 15].   
 The major strength of this study is that all 
cases and controls were confirmed by allergen-
specific skin prick tests to nineteen common 
allergens. Second, data on weight and height of both 
cases and controls were obtained through direct 
physical measurements, conducted by a physician, 
which should be more accurate and reliable than self-
reported values. Third, none of the participants was 
treated with steroids or other hormonal therapy prior 
to involvement in this survey. 
 Limitation to our study is a lack of measures 
of adiposity other than BMI, which was used to define 
overweight and obesity, so we were not able to 
distinguish central from peripheral obesity. 
Furthermore the fact that women tend to have more 
fat mass and men more muscle mass may also 
contribute to apparently gender specific relation 
between obesity and asthma. Second, the sample 
size was relatively small for some atopic disorders, 
especially when assessing gender based association 
between allergic asthma and obesity and between 
genders in healthy controls. Therefore it is possible 
that obesity is truly associated with allergic asthma in 
males but we failed to detect such association 
because of a low statistical power of our data an d 
also because age unmatched male controls. Taken all 
together, further studies are needed to investigate the 
association between obesity and asthma in males. 
This study has confirmed that our male subjects with 
allergic diseases are more overweight compared to 
females with the same diseases, but overweight is 
associated with asthma in females only. High BMI is 
also associated with atopy in healthy females and 
males. Median of total IgE levels is higher in male 
patients within all allergic diseases in respect to 
females, but there are no significant differences 
between gender, BMI and total IgE levels. Also this 
study extended observations to prove associations of 
high BMI with symptoms of eczema/urticaria in both 
genders. The observations and findings reported from 
this study should by no means be neglected, while 
additional research with larger sample size is 
necessary to verify if weight loss would mitigate or 
prevent symptoms of urticaria/eczema and asthma. 
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